Screener
Haemonetics HAE Income Tax
Income Tax at other companies
Other financials
Where this comes from
Reported directly by Haemonetics in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.
The source filing: Haemonetics’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 6:09 AM EDT
- Fiscal quarter
- Q1 FY2027
- Calendar quarter
- Q2 2026
- Accession
- 0000313143-26-000120
| Line item | Three Months Ended / June 27, 2026 | Three Months Ended / June 28, 2025 |
|---|---|---|
| Operating income | 57,458 | 53,872 |
| Interest and other expense, net | (9,884) | (8,703) |
| Income before provision for income taxes | 47,574 | 45,169 |
| Provision for income taxes | 14,564 | 11,138 |
| Net income | $33,010 | $34,031 |
| Net income per common share: | ||
| Basic | $0.73 | $0.71 |
| Diluted | $0.72 | $0.70 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Haemonetics's income tax?
- Haemonetics (HAE) reported income tax of $14.56M in Q2 2026.
- How has Haemonetics's income tax changed year-over-year?
- Haemonetics's income tax increased by 30.8% year-over-year, from $11.14M to $14.56M.
- What is the long-term trend for Haemonetics's income tax?
- Over 3 years (2022 to 2025), Haemonetics's income tax has grown at a 29.9% compound annual growth rate (CAGR), from $20.25M to $44.39M.
- What does income tax mean?
- Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.
Ask your AI about Haemonetics's income tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude